HUMAN GENE THERAPY RES INST has a total of 16 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and telecommunications are DCPRIME B V, BIOMICS BIOTECHNOLOGIES CO LTD and FLUGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Telecommunications |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Transmission | |
#5 | Peptides | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Link Charles J Jr | 8 |
#2 | Link Jr Charles J | 6 |
#3 | Panchal Rekha G | 5 |
#4 | Seregina Tatiana | 4 |
#5 | Ramsey William J | 4 |
#6 | Higginbotham James N | 4 |
#7 | Link Charles J | 2 |
#8 | Levy John P | 1 |
#9 | Mandell Robert B | 1 |
#10 | Wang Suming | 1 |
Publication | Filing date | Title |
---|---|---|
US2005266544A1 | Methods and compositions for increasing viral vector production in packaging cell lines | |
US2006216271A1 | Methods and compositions for efficient gene transfer using transcomplementary vectors | |
US7005126B1 | Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect | |
EP1045902A1 | HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME | |
US6541197B2 | Vehicles for stable transfer of green fluorescent protein gene and methods of use for same |